USANA Health Sciences, Inc. (NYSE: USNA) is a Consumer Defensive company (Packaged Foods) with a market capitalization of $251M. The Maz Rating grades it against the other companies in its sector.
USANA Health Sciences, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $13.57, USANA Health Sciences, Inc. trades at 0.3x sales and 0.5x book value, with an EV/EBITDA of 2.1. Over the last twelve months it generated about $905M of revenue and a net loss of $21M. It runs a gross margin of 77.3%, an operating margin of 1.1% and a net margin of -2.3%. It shows return on equity of -4.0%, return on invested capital of 1.6% and a free cash flow yield of 11.7%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 2.59. Over the past 52 weeks the share price ranged from $12.53 to $23.59, with a beta of 0.67.
USANA Health Sciences, Inc. does not currently pay a dividend.
8 Wall Street analyst ratings cover the stock: 2 Buy, 5 Hold and 1 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.